Literature DB >> 16343884

Systems biology of neutrophil differentiation and immune response.

Kim Theilgaard-Mönch1, Bo T Porse, Niels Borregaard.   

Abstract

Systems biology has emerged as a new scientific field, which aims at investigating biological processes at the genomic and proteomic levels. Recent studies have unravelled aspects of neutrophil differentiation and immune responses at the systems level using high-throughput technologies. These studies have identified a plethora of novel effector proteins stored in the granules of neutrophils. In addition, these studies provide evidence that neutrophil differentiation and immune response are governed by a highly coordinated transcriptional programme that regulates cellular fate and function in a context-dependent manner.

Mesh:

Substances:

Year:  2005        PMID: 16343884     DOI: 10.1016/j.coi.2005.11.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  24 in total

1.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

2.  Inflammation-induced proteolytic processing of the SIRPα cytoplasmic ITIM in neutrophils propagates a proinflammatory state.

Authors:  Ke Zen; Yalan Guo; Zhen Bian; Zhiyuan Lv; Dihan Zhu; Hiroshi Ohnishi; Takashi Matozaki; Yuan Liu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  Leukocytes in glomerular injury.

Authors:  Stephen R Holdsworth; Peter G Tipping
Journal:  Semin Immunopathol       Date:  2007-10-16       Impact factor: 9.623

4.  Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections.

Authors:  Zhuoming Liu; Robert Petersen; Laxminarayana Devireddy
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

5.  In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils.

Authors:  J M Paulsson; A Moshfegh; E Dadfar; C Held; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

6.  Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.

Authors:  Sujin Chanchamroen; Chidchamai Kewcharoenwong; Wattanachai Susaengrat; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

7.  Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.

Authors:  Megha Makam; Daisy Diaz; Julie Laval; Yael Gernez; Carol K Conrad; Colleen E Dunn; Zoe A Davies; Richard B Moss; Leonore A Herzenberg; Leonard A Herzenberg; Rabindra Tirouvanziam
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-17       Impact factor: 11.205

8.  Nuclear-to-cytoplasmic relocalization of the proliferating cell nuclear antigen (PCNA) during differentiation involves a chromosome region maintenance 1 (CRM1)-dependent export and is a prerequisite for PCNA antiapoptotic activity in mature neutrophils.

Authors:  Dikra Bouayad; Magali Pederzoli-Ribeil; Julie Mocek; Céline Candalh; Jean-Benoît Arlet; Olivier Hermine; Nathalie Reuter; Noélie Davezac; Véronique Witko-Sarsat
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

9.  Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses.

Authors:  Shih-Kuang Yang; Yu-Chao Wang; Chun-Cheih Chao; Yung-Jen Chuang; Chung-Yu Lan; Bor-Sen Chen
Journal:  BMC Med Genomics       Date:  2010-05-24       Impact factor: 3.063

10.  Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival.

Authors:  Véronique Witko-Sarsat; Julie Mocek; Dikra Bouayad; Nicola Tamassia; Jean-Antoine Ribeil; Céline Candalh; Noélie Davezac; Nathalie Reuter; Luc Mouthon; Olivier Hermine; Magali Pederzoli-Ribeil; Marco A Cassatella
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.